MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
96.75
+0.46
+0.48%
After Hours: 96.99 +0.24 +0.25% 19:53 04/08 EDT
OPEN
98.99
PREV CLOSE
96.29
HIGH
99.00
LOW
95.80
VOLUME
1.20M
TURNOVER
--
52 WEEK HIGH
124.49
52 WEEK LOW
29.17
MARKET CAP
19.17B
P/E (TTM)
-16.2600
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Compugen (CGEN), Revolution Medicines (RVMD)
TipRanks · 1d ago
LifeSci Capital Sticks to Its Buy Rating for Revolution Medicines (RVMD)
TipRanks · 2d ago
Weekly Report: what happened at RVMD last week (0330-0403)?
Weekly Report · 2d ago
A Look At Revolution Medicines (RVMD) Valuation After Starting Pivotal Phase 3 RASolute 303 Trial
Simply Wall St · 3d ago
Tango a new Buy at Canaccord Genuity on 2026 catalysts
Seeking Alpha · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Nuo Therapeutics (AURX)
TipRanks · 6d ago
Revolution Medicines begins treating patients in RASolute 303
TipRanks · 6d ago
Revolution Medicines starts Phase 3 RASolute 303 trial of daraxonrasib in metastatic pancreatic cancer
Reuters · 6d ago
More
About RVMD
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.